Investigates the key genomic change in cancers and reproduce and demonstrate the effect in vitro/vivo
My research interest is focused on investigating key regulatory genes/elements and pathways involved in cancer development from the perspective of genetic alterations. In particular, I am interested in identification of characteristic genetic change which explains phenotype or sensitivity to drugs in a subset of tumors. Moreover, by the integration of next-generation sequencing data with the use of in vivo/vitro patient-derived xenografts and cancer cells, I aim to reproduce and demonstrate their involvement in cancer development. These developed models not only help the better understanding of the mechanism underlie a subset of tumors but also helps the development of novel approaches toward the personalized treatment for patients.
The Jackson Laboratory
Postdoctoral Associate
Adv: Edison Liu
2017-2019
RIKEN (Japan)
Research Fellow
Adv: Hidewaki Nakagawa
2012-2017
Tokyo Medical and Dental University (Japan)
Ph.D., Molecular Biology
Adv: Johji Inazawa
2009-2012
Tokyo Medical and Dental University (Japan)
MSc., Molecular Biology
2007-2009
Tokyo University of Science (Japan)
B.S., Biology
2007
The Jackson Laboratory
Associate Research ScientistAdv: Edison Liu
2019-present
Tokyo Medical and Dental University (Japan)
Research Assistant
2008-2009, 2011-2012